Some 20% of people with axial spondyloarthritis (axSpA) included in a prospective cohort study showed no lesions in their ...

Even with disease-modifying therapies, patients who have chronically active inflammatory MS lesions can expect an aggressive disease course and poor outcomes. A new study shows that patients with ≥4 ...